======= ABCD3 =======
== Gene Information ==
* **Official Symbol**: ABCD3
* **Official Name**: ATP binding cassette subfamily D member 3
* **Aliases and Previous Symbols**: N/A
* **Entrez ID**: [[https://www.ncbi.nlm.nih.gov/gene/?term=5825|5825]]
* **UniProt**: [[https://www.uniprot.org/uniprot/P28288|P28288]]
* **Interactions**: [[https://thebiogrid.org/search.php?search=ABCD3&organism=9606|BioGRID]]
* **PubMed articles**: [[https://www.ncbi.nlm.nih.gov/pubmed/?term=gene%20ABCD3|Open PubMed]]
* **OMIM**: [[https://omim.org/entry/170995|Open OMIM]]
== Function Summary ==
* **Entrez Summary**: The protein encoded by this gene is a member of the superfamily of ATP-binding cassette (ABC) transporters. ABC proteins transport various molecules across extra- and intra-cellular membranes. ABC genes are divided into seven distinct subfamilies (ABC1, MDR/TAP, MRP, ALD, OABP, GCN20, White). This protein is a member of the ALD subfamily, which is involved in peroxisomal import of fatty acids and/or fatty acyl-CoAs in the organelle. All known peroxisomal ABC transporters are half transporters which require a partner half transporter molecule to form a functional homodimeric or heterodimeric transporter. This peroxisomal membrane protein likely plays an important role in peroxisome biogenesis. Mutations have been associated with some forms of Zellweger syndrome, a heterogeneous group of peroxisome assembly disorders. Alternative splicing results in multiple transcript variants encoding distinct isoforms. [provided by RefSeq, Jul 2008].
* **UniProt Summary**: Probable transporter involved in the transport of branched-chain fatty acids and C27 bile acids into the peroxisome; the latter function is a crucial step in bile acid biosynthesis (PubMed:25168382). The nucleotide-binding fold acts as an ATP- binding subunit with ATPase activity (PubMed:11248239). {ECO:0000269|PubMed:11248239, ECO:0000269|PubMed:25168382}.
|ABC membrane 2|
|ABC tran|
|long-chain fatty acid import into peroxisome|
|very long-chain fatty acid catabolic process|
|long-chain fatty acid transporter activity|
|fatty acid transmembrane transport|
|peroxisomal membrane transport|
|very long-chain fatty acid metabolic process|
|intracellular lipid transport|
|peroxisomal matrix|
|ATPase-coupled transmembrane transporter activity|
|protein self-association|
|peroxisomal membrane|
|fatty acid beta-oxidation|
|long-chain fatty acid transport|
|peroxisomal transport|
|fatty acid transport|
|fatty acid oxidation|
|lipid oxidation|
|peroxisome organization|
|fatty acid catabolic process|
|peroxisome|
|monocarboxylic acid catabolic process|
|fatty acid biosynthetic process|
|organic acid transmembrane transport|
|carboxylic acid transmembrane transport|
|monocarboxylic acid transport|
|monocarboxylic acid biosynthetic process|
|cellular lipid catabolic process|
|lipid modification|
|ATPase activity|
|carboxylic acid catabolic process|
|organic acid catabolic process|
|anion transmembrane transport|
|carboxylic acid transport|
|organic acid transport|
|lipid transport|
|lipid catabolic process|
|carboxylic acid biosynthetic process|
|organic acid biosynthetic process|
|lipid localization|
|fatty acid metabolic process|
|small molecule catabolic process|
|organic anion transport|
|monocarboxylic acid metabolic process|
|lipid biosynthetic process|
|anion transport|
|small molecule biosynthetic process|
|intracellular membrane-bounded organelle|
|protein homodimerization activity|
|carboxylic acid metabolic process|
|response to organic cyclic compound|
|ion transmembrane transport|
|cellular lipid metabolic process|
|oxidation-reduction process|
|oxoacid metabolic process|
|response to drug|
|organic acid metabolic process|
|lipid metabolic process|
|mitochondrion|
|transmembrane transport|
|ion transport|
|ATP binding|
|intracellular transport|
|small molecule metabolic process|
|organic substance catabolic process|
|cellular catabolic process|
|establishment of localization in cell|
|membrane|
\\
=== CRISPR Data ===
^Screen^Score^
|[[:results:exp98|BI-6727 0.04μM R03 exp98]]|1.81|
|[[:results:exp226|Cerivastatin 0.15μM R05 exp226]]|5.28|
|[[:results:exp282|Fluvastatin 2.2μM R06 exp282]]|6.02|
^Gene^Correlation^
|[[:human genes:l:ldlrap1|LDLRAP1]]|0.468|
|[[:human genes:p:pex3|PEX3]]|0.443|
Global Fraction of Cell Lines Where Essential: 1/739
^Tissue^Fraction Of Cell Lines Where Essential^
|1290807.0|0/1|
|909776.0|0/1|
|bile duct|0/28|
|blood|0/28|
|bone|0/26|
|breast|0/33|
|central nervous system|0/56|
|cervix|0/4|
|colorectal|0/17|
|esophagus|0/13|
|fibroblast|0/1|
|gastric|0/16|
|kidney|0/21|
|liver|0/20|
|lung|0/75|
|lymphocyte|0/16|
|ovary|0/26|
|pancreas|0/24|
|peripheral nervous system|1/16|
|plasma cell|0/15|
|prostate|0/1|
|skin|0/24|
|soft tissue|0/9|
|thyroid|0/2|
|upper aerodigestive|0/22|
|urinary tract|0/29|
|uterus|0/5|
== Essentiality in NALM6 ==
* **Essentiality Rank**: 15867
* **Expression level (log2 read counts)**: 6.33
{{:chemogenomics:nalm6 dist.png?nolink |}}